Use of Injectable-platelet-rich-fibrin (I-PRF) to Thicken Gingival Phenotype
- Conditions
- Blood ClotPeriodontoclasiaConditionGingiva DisorderGingiva; Injury
- Interventions
- Other: I-PRF
- Registration Number
- NCT03274674
- Lead Sponsor
- Bezmialem Vakif University
- Brief Summary
The main objective of this study is to investigate whether the for individuals with thin gingival thickness who are susceptible to gingival recession, the investigators will use i-PRF with microneedle to increase gingival thickness without the need for surgical procedures
- Detailed Description
Due to the thin gingival phenotype, gingival recession is a problem. The investigators aimed to increase the gingival thickness using i-PRF with microneedle without considering surgical procedures, considering the positive effects of platelet concentrations on revascularization and wound healing in individuals with bone defect, fenestration and gingival thickness which are prone to gingival recession .
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 29
- Never smokers
- Had no history of systemic disease
- Aged ≥18 years old
- Patients with a history of diabetes mellitus or systemic disease
- Patients who were under any medication that was known to influence periodontal tissues
- Patients with hormonal changes such as pregnancy or lactation
- Toothless individuals
- Patients who were clotting disorders
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description I-PRF I-PRF Venous blood will be taken from the patient every session and I-PRF will be created in the centrifuge.I-PRF injected on one side of bilateral thin gingival thickness.Apply once a week and one month after the end of the injections, the patient will be called to the control. I-PRF and Microneedling I-PRF Venous blood will be taken from the patient every session and I-PRF will be created in the centrifuge.Microneedle application plus I-PRF injected on the other side in patients with bilateral region with thin gingival phenotype.Apply once a week and one month after the end of the injections, the patient will be called to the control.
- Primary Outcome Measures
Name Time Method Gingival thickness (mm) 2 months Change in clinical measures of gingival thickness
- Secondary Outcome Measures
Name Time Method Plaque Index (PI) 2 months Change in clinical measures of gingival parameters
Bleeding on probing (BOP) 2 months Change in clinical measures of gingival parameters
Gingival Index (GI) 2 months Change in clinical measures of gingival parameters
Clinical attachment level (CAL) 2 months Change in clinical measures of gingival parameters
Probing pocket depth (PD) 2 months Change in clinical measures of gingival parameters
Trial Locations
- Locations (1)
Zeliha Betül ÖZSAĞIR
🇹🇷İstanbul, Turkey